Pasithea Therapeutics Corp. (KTTA)
NCM · Common · CUSIP 70261F103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for KTTA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
70261F103
Market Cap
Micro Cap
IPO
9/15/2021
Business: Pasithea Therapeutics Corp. i biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. The flagship company program is focused on discovering new and effective treatments for mental health problems.

Company Contact

CEO
Tiago Reis Marques
CFO
Dan Schneiderman
Headquarters
1111 Lincoln Road, Suite 500, Miami Beach, FL 33139
Phone
702-514-4174
Investor Relations
info@pasithea.com
SEC EDGAR Filings
View filings »
Find all related securities for KTTA »